{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:48:35Z","timestamp":1794955715677,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04078-9","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:37:50Z","timestamp":1747733870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Efficacy of topical mesenchymal stem cell exosome in Sj\u00f6gren\u2019s syndrome-related dry eye: a randomized clinical trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Azam","family":"Habibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Nejabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahintaj","family":"Dara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Azarpira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"3","key":"4078_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3341\/kjo.2019.0145","volume":"34","author":"KY Kook","year":"2020","unstructured":"Kook KY, et al. Tear osmolarity and matrix Metallopeptidase-9 in dry eye associated with Sj\u00f6gren\u2019s syndrome. Korean J Ophthalmol. 2020;34(3):179\u201386.","journal-title":"Korean J Ophthalmol"},{"issue":"12","key":"4078_CR2","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1167\/iovs.08-2075","volume":"49","author":"KF Siemasko","year":"2008","unstructured":"Siemasko KF, et al. In vitro expanded CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci. 2008;49(12):5434\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"4078_CR3","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1167\/iovs.08-2476","volume":"50","author":"S Chotikavanich","year":"2009","unstructured":"Chotikavanich S, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009;50(7):3203\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"4078_CR4","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1167\/iovs.04-0299","volume":"45","author":"DQ Li","year":"2004","unstructured":"Li DQ, et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45(12):4302\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4078_CR5","unstructured":"Li D-Q, et al. Hyperosmolarity stimulates production of MMP-9, IL-1\u00df and TNF- by human corneal epithelial cells via a c-Jun NH2-terminal kinase pathway. Volume 43. Investigative Ophthalmology & Visual Science; 2002. pp. 1981\u20131981. 13."},{"key":"4078_CR6","doi-asserted-by":"crossref","unstructured":"Wu KY et al. An Overview of the Dry Eye Disease in Sj\u00f6gren\u2019s Syndrome Using Our Current Molecular Understanding. Int J Mol Sci, 2023. 24(2).","DOI":"10.3390\/ijms24021580"},{"key":"4078_CR7","doi-asserted-by":"publisher","first-page":"676885","DOI":"10.3389\/fmed.2021.676885","volume":"8","author":"C Vitali","year":"2021","unstructured":"Vitali C, et al. Management of Sj\u00f6gren\u2019s syndrome: present issues and future perspectives. Front Med (Lausanne). 2021;8:676885.","journal-title":"Front Med (Lausanne)"},{"issue":"15","key":"4078_CR8","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood. 2012;120(15):3142\u201351.","journal-title":"Blood"},{"issue":"7","key":"4078_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musia\u0142-Wysocka","year":"2019","unstructured":"Musia\u0142-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem Cell-Based therapies. Cell Transpl. 2019;28(7):801\u201312.","journal-title":"Cell Transpl"},{"key":"4078_CR10","doi-asserted-by":"publisher","first-page":"1097456","DOI":"10.3389\/fimmu.2023.1097456","volume":"14","author":"A Habibi","year":"2023","unstructured":"Habibi A, et al. Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature. Front Immunol. 2023;14:1097456.","journal-title":"Front Immunol"},{"issue":"1","key":"4078_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12967-023-04198-0","volume":"21","author":"S Hu","year":"2023","unstructured":"Hu S, et al. Dental pulp stem cell-derived exosomes revitalize salivary gland epithelial cell function in NOD mice via the GPER-mediated cAMP\/PKA\/CREB signaling pathway. J Transl Med. 2023;21(1):361.","journal-title":"J Transl Med"},{"key":"4078_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.addr.2020.03.002","volume":"159","author":"T Skotland","year":"2020","unstructured":"Skotland T, et al. An emerging focus on lipids in extracellular vesicles. Adv Drug Deliv Rev. 2020;159:308\u201321.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4078_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","volume":"113","author":"JC Akers","year":"2013","unstructured":"Akers JC, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1\u201311.","journal-title":"J Neurooncol"},{"key":"4078_CR14","doi-asserted-by":"crossref","unstructured":"Habibi A et al. Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature. 2023. 14.","DOI":"10.3389\/fimmu.2023.1097456"},{"issue":"3","key":"4078_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11481-019-09875-w","volume":"15","author":"F Shahjin","year":"2020","unstructured":"Shahjin F, Chand S, Yelamanchili SV. Extracellular vesicles as drug delivery vehicles to the central nervous system. J Neuroimmune Pharmacol. 2020;15(3):443\u201358.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"4078_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s13287-022-03122-5","volume":"13","author":"H Yari","year":"2022","unstructured":"Yari H, et al. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Res Ther. 2022;13(1):423.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4078_CR17","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","volume":"376","author":"AE Kuriyan","year":"2017","unstructured":"Kuriyan AE, et al. Vision loss after intravitreal injection of autologous stem cells for AMD. N Engl J Med. 2017;376(11):1047\u201353.","journal-title":"N Engl J Med"},{"key":"4078_CR18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3389\/fphar.2018.01199","volume":"9","author":"GD Kusuma","year":"2018","unstructured":"Kusuma GD, et al. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front Pharmacol. 2018;9:1199.","journal-title":"Front Pharmacol"},{"issue":"11","key":"4078_CR19","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss ML, et al. Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells. Stem Cells. 2008;26(11):2865\u201374.","journal-title":"Stem Cells"},{"issue":"B","key":"4078_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3889\/oamjms.2020.5305","volume":"8","author":"D Astaridewi","year":"2020","unstructured":"Astaridewi D, et al. Topical instillation of Resveratrol preconditioned Wharton\u2019s jelly mesenchymal stem cell secretome preserves ocular surface in experimental model of severe dry eye disease. Open Access Macedonian J Med Sci. 2020;8(B):1116\u201323.","journal-title":"Open Access Macedonian J Med Sci"},{"key":"4078_CR21","doi-asserted-by":"publisher","first-page":"879192","DOI":"10.3389\/fbioe.2022.879192","volume":"10","author":"S Ma","year":"2022","unstructured":"Ma S, et al. Exosomes from human umbilical cord mesenchymal stem cells treat corneal injury via autophagy activation. Front Bioeng Biotechnol. 2022;10:879192.","journal-title":"Front Bioeng Biotechnol"},{"key":"4078_CR22","doi-asserted-by":"publisher","first-page":"p250230","DOI":"10.1155\/2014\/250230","volume":"2014","author":"E Beyazy\u0131ld\u0131z","year":"2014","unstructured":"Beyazy\u0131ld\u0131z E, et al. Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model. Stem Cells Int. 2014;2014:p250230.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4078_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, et al. 2016 American college of rheumatology\/european league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and Data-Driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35\u201345.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"4078_CR24","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1167\/iovs.11-8027","volume":"52","author":"BE Dougherty","year":"2011","unstructured":"Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the ocular surface disease index (OSDI). Invest Ophthalmol Vis Sci. 2011;52(12):8630\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"4078_CR25","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.18240\/ijo.2019.10.15","volume":"12","author":"AM Elhusseiny","year":"2019","unstructured":"Elhusseiny AM, et al. New approaches for diagnosis of dry eye disease. Int J Ophthalmol. 2019;12(10):1618\u201328.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"4078_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1475-1313.1998.00385.x","volume":"18","author":"P Cho","year":"1998","unstructured":"Cho P, et al. Tear break-up time: clinical procedures and their effects. Ophthalmic Physiol Opt. 1998;18(4):319\u201324.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"7","key":"4078_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640\u201350.","journal-title":"Cornea"},{"issue":"2","key":"4078_CR28","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar4514","volume":"16","author":"D Cornec","year":"2014","unstructured":"Cornec D, et al. Level of agreement between 2002 American-European consensus group and 2012 American college of rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome and reasons for discrepancies. Arthritis Res Ther. 2014;16(2):R74.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"4078_CR29","first-page":"167","volume":"11","author":"M Dara","year":"2022","unstructured":"Dara M, et al. Novel RNA extraction method from human tears. Mol Biol Res Commun. 2022;11(4):167\u201372.","journal-title":"Mol Biol Res Commun"},{"issue":"10","key":"4078_CR30","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.4049\/jimmunol.174.10.6440","volume":"174","author":"SH Kim","year":"2005","unstructured":"Kim SH, et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol. 2005;174(10):6440\u20138.","journal-title":"J Immunol"},{"issue":"9535","key":"4078_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(06)69207-6","volume":"368","author":"PS Severn","year":"2006","unstructured":"Severn PS, Fraser SG. Bilateral cataracts and glaucoma induced by long-term use of oral prednisolone bought over the internet. Lancet. 2006;368(9535):618.","journal-title":"Lancet"},{"issue":"30","key":"4078_CR32","doi-asserted-by":"publisher","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy O, et al. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020;6(30):eaba6884.","journal-title":"Sci Adv"},{"key":"4078_CR33","doi-asserted-by":"publisher","first-page":"p4357865","DOI":"10.1155\/2018\/4357865","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, et al. Mesenchymal stem cells in primary Sj\u00f6gren\u2019s syndrome: prospective and challenges. Stem Cells Int. 2018;2018:p4357865.","journal-title":"Stem Cells Int"},{"issue":"10","key":"4078_CR34","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.biocel.2010.06.012","volume":"42","author":"DL Faustman","year":"2010","unstructured":"Faustman DL, Davis M. Stem cells in the spleen: therapeutic potential for Sjogren\u2019s syndrome, type I diabetes, and other disorders. Int J Biochem Cell Biol. 2010;42(10):1576\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"4078_CR35","first-page":"954","volume":"13","author":"B Gong","year":"2020","unstructured":"Gong B, et al. Murine embryonic mesenchymal stem cells attenuated Xerostomia in Sj\u00f6gren-like mice via improving salivary gland epithelial cell structure and secretory function. Int J Clin Exp Pathol. 2020;13(5):954\u201363.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"4078_CR36","doi-asserted-by":"publisher","first-page":"eabj9617","DOI":"10.1126\/sciadv.abj9617","volume":"8","author":"T Zhou","year":"2022","unstructured":"Zhou T, et al. miR-204-containing exosomes ameliorate GVHD-associated dry eye disease. Sci Adv. 2022;8(2):eabj9617.","journal-title":"Sci Adv"},{"key":"4078_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jtos.2020.04.014","volume":"19","author":"L Latta","year":"2021","unstructured":"Latta L, et al. Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered MicroRNA and gene expression modulated by PAX6 mutational status in congenital aniridia. Ocul Surf. 2021;19:115\u201327.","journal-title":"Ocul Surf"},{"issue":"1","key":"4078_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40246-020-00258-4","volume":"14","author":"A Shiels","year":"2020","unstructured":"Shiels A. TRPM3_miR-204: a complex locus for eye development and disease. Hum Genomics. 2020;14(1):7.","journal-title":"Hum Genomics"},{"key":"4078_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.omtn.2017.12.019","volume":"10","author":"Y Lu","year":"2018","unstructured":"Lu Y, et al. Transcriptome profiling of neovascularized Corneas reveals miR-204 as a Multi-target biotherapy deliverable by rAAVs. Mol Ther Nucleic Acids. 2018;10:349\u201360.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"4078_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, et al. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26(4):431\u20137.","journal-title":"Cornea"},{"issue":"5","key":"4078_CR41","first-page":"1429","volume":"43","author":"D Zoukhri","year":"2002","unstructured":"Zoukhri D, et al. Role of Proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci. 2002;43(5):1429\u201336.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"4078_CR42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","volume":"28","author":"ML Massingale","year":"2009","unstructured":"Massingale ML, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023\u20137.","journal-title":"Cornea"},{"key":"4078_CR43","doi-asserted-by":"publisher","first-page":"p636812","DOI":"10.1155\/2013\/636812","volume":"2013","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz L, et al. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm. 2013;2013:p636812.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"4078_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9394(03)00203-4","volume":"136","author":"Y Ohashi","year":"2003","unstructured":"Ohashi Y, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol. 2003;136(2):291\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4078_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen DK, et al. Reassessment of exosome composition. Cell. 2019;177(2):428\u2013e44518.","journal-title":"Cell"},{"key":"4078_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Exosomes Annu Rev Biochem"},{"issue":"10","key":"4078_CR47","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19(10):1769\u201379.","journal-title":"Mol Ther"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:13:44Z","timestamp":1747736024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4078"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04078-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before their inclusion in the study, written informed consent was obtained from the WJ tissue donors and participants with SS. The trial was conducted in accordance with the guidelines for conducting clinical trials on human participants and the Declaration of Helsinki. Shiraz University of Medical Sciences Ethics Committee, Shiraz, Iran, approved the study protocol (IR.SUMS.REC.1400.852). The study protocol was also registered in the Iranian Registry of Clinical Trials (IRCT20211102052948N1) at 2022-04-20.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Before the participant enters the study, written informed consent was obtained from WJ tissue donors and SS participants for the publication of results that will be used in a completely confidential manner and solely for research purposes, and the participants\u2019 identity will remain confidential within the framework of the law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}